The World's Greatest Investing Community
Results 1 - 10 of 80 : 1 2 3 4 5 6 7 8 Next
Drug Approval! Oh, Wait, We Knew That Already.
Cell Therapeutics shares jump on a non-event.
Cell Therapeutics licenses a drug at an inopportune time.
3 Biotechs You Should Have Sold Years Ago
Even with good news, these biotechs are long-term losers.
What's Going on With These Biotech Stocks?
Here's the news at some of the most interesting biotechs.
Those Europeans Will Approve (Almost) Anything
Too bad most of the money to be made is stateside.
Our investing community's latest prime pick to avoid: Cell Therapeutics.
Dow Poised to End the Week on Solid Ground
The Dow's holding on to yesterday's gains.
The Skinny on Upcoming Obesity FDA Meetings
Mark your calendars.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK